Working Group 3 (WG3)Joint Observatory Agreement • June 28th, 2013
Contract Type FiledJune 28th, 2013Mo-99 is the most important radionuclide in nuclear medicine. It is used to produce Tc-99m generators which are used in more than 30 million diagnostic nuclear medicine procedures around the world each year. Tc-99m is used in more than 100 different types of diagnostic nuclear medicine procedures including evaluation of myocardial function, detection and staging of cancer, brain disorders, infections and many other diseases. Accordingly, a stable and sustained supply of Mo-99 must accompany the conversion process from the use of Highly Enriched Uranium (HEU) to Low-Enriched Uranium (LEU) to manufacture targets for irradiation in the nuclear reactor.